GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fermenta Biotech Ltd (BOM:506414) » Definitions » Cyclically Adjusted PS Ratio

Fermenta Biotech (BOM:506414) Cyclically Adjusted PS Ratio : 1.94 (As of May. 06, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Fermenta Biotech Cyclically Adjusted PS Ratio?

As of today (2025-05-06), Fermenta Biotech's current share price is ₹265.40. Fermenta Biotech's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was ₹136.65. Fermenta Biotech's Cyclically Adjusted PS Ratio for today is 1.94.

The historical rank and industry rank for Fermenta Biotech's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:506414' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.9   Med: 1.97   Max: 3.79
Current: 1.88

During the past years, Fermenta Biotech's highest Cyclically Adjusted PS Ratio was 3.79. The lowest was 0.90. And the median was 1.97.

BOM:506414's Cyclically Adjusted PS Ratio is ranked better than
53.28% of 732 companies
in the Drug Manufacturers industry
Industry Median: 2.03 vs BOM:506414: 1.88

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Fermenta Biotech's adjusted revenue per share data for the three months ended in Dec. 2024 was ₹53.879. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹136.65 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Fermenta Biotech Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Fermenta Biotech's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fermenta Biotech Cyclically Adjusted PS Ratio Chart

Fermenta Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.52 1.90 0.90 1.19

Fermenta Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.19 1.28 2.29 2.66

Competitive Comparison of Fermenta Biotech's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Fermenta Biotech's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fermenta Biotech's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fermenta Biotech's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fermenta Biotech's Cyclically Adjusted PS Ratio falls into.


;
;

Fermenta Biotech Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Fermenta Biotech's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=265.40/136.65
=1.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fermenta Biotech's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Fermenta Biotech's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=53.879/158.3229*158.3229
=53.879

Current CPI (Dec. 2024) = 158.3229.

Fermenta Biotech Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 14.844 97.163 24.188
201506 13.754 99.841 21.810
201509 13.955 101.753 21.713
201512 13.485 102.901 20.748
201603 14.787 102.518 22.836
201606 15.386 105.961 22.989
201609 14.571 105.961 21.771
201612 13.658 105.196 20.556
201703 16.021 105.196 24.112
201706 15.862 107.109 23.446
201709 23.190 109.021 33.677
201712 35.739 109.404 51.719
201803 35.277 109.786 50.873
201806 30.329 111.317 43.136
201809 42.039 115.142 57.805
201812 38.654 115.142 53.150
201903 31.655 118.202 42.400
201906 28.070 120.880 36.765
201909 27.954 123.175 35.931
201912 22.994 126.235 28.839
202003 22.070 124.705 28.020
202006 32.701 127.000 40.766
202009 32.308 130.118 39.311
202012 31.136 130.889 37.662
202103 32.102 131.771 38.571
202106 37.996 134.084 44.865
202109 34.623 135.847 40.351
202112 32.213 138.161 36.914
202203 32.975 138.822 37.607
202206 31.895 142.347 35.475
202209 34.091 144.661 37.311
202212 19.013 145.763 20.651
202303 34.586 146.865 37.284
202306 28.794 150.280 30.335
202309 19.708 151.492 20.597
202312 34.267 152.924 35.477
202403 31.463 153.035 32.550
202406 26.988 155.789 27.427
202409 32.902 157.882 32.994
202412 53.879 158.323 53.879

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Fermenta Biotech  (BOM:506414) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Fermenta Biotech Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Fermenta Biotech's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Fermenta Biotech Business Description

Traded in Other Exchanges
N/A
Address
Ghodbunder Road, A -1501, Thane One, DIL Complex, Majiwada, Thane (West), Thane, MH, IND, 400610
Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments that are Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.

Fermenta Biotech Headlines

No Headlines